We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
651
Revvity
RVTY
$12.7B
$6.73K ﹤0.01%
61
NMR icon
652
Nomura Holdings
NMR
$29B
$6.72K ﹤0.01%
766
SNPS icon
653
Synopsys
SNPS
$77.7B
$6.69K ﹤0.01%
15
-5
-25% -$2.35K
KDP icon
654
Keurig Dr Pepper
KDP
$41.3B
$6.51K ﹤0.01%
199
FIVE icon
655
Five Below
FIVE
$12.8B
$6.47K ﹤0.01%
36
SOLS
656
Solstice Advanced Materials
SOLS
$9.88B
$6.47K ﹤0.01%
73
NOW icon
657
ServiceNow
NOW
$121B
$6.45K ﹤0.01%
65
-75
-54% -$7.43K
ROK icon
658
Rockwell Automation
ROK
$49.2B
$6.44K ﹤0.01%
13
RVMD icon
659
Revolution Medicines
RVMD
$42.1B
$6.37K ﹤0.01%
+34
New +$4.97K
KHC icon
660
Kraft Heinz
KHC
$29.6B
$6.33K ﹤0.01%
268
-15
-5% -$346
ALNY icon
661
Alnylam Pharmaceuticals
ALNY
$28.9B
$6.32K ﹤0.01%
21
+1
+5% +$302
TAP icon
662
Molson Coors Class B
TAP
$7.95B
$6.31K ﹤0.01%
162
UMH
663
UMH Properties
UMH
$1.34B
$6.3K ﹤0.01%
416
QGEN icon
664
Qiagen
QGEN
$8.61B
$6.26K ﹤0.01%
160
ZTS icon
665
Zoetis
ZTS
$32.4B
$6.24K ﹤0.01%
87
EFX icon
666
Equifax
EFX
$20.7B
$6.19K ﹤0.01%
39
-40
-51% -$6.82K
JBL icon
667
Jabil
JBL
$36.1B
$6.17K ﹤0.01%
16
+7
+78% +$2.42K
STLA icon
668
Stellantis
STLA
$20.9B
$6.14K ﹤0.01%
1,071
HSY icon
669
Hershey
HSY
$36.8B
$6.14K ﹤0.01%
35
ALB icon
670
Albemarle
ALB
$14.8B
$6.08K ﹤0.01%
45
QQQI icon
671
NEOS Nasdaq 100 High Income ETF
QQQI
$13.9B
$6.02K ﹤0.01%
106
+4
+4% +$220
PNR icon
672
Pentair
PNR
$11.2B
$5.98K ﹤0.01%
78
FICO icon
673
Fair Isaac
FICO
$22.3B
$5.97K ﹤0.01%
+5
New +$5.6K
BOKF icon
674
BOK Financial
BOKF
$8.78B
$5.97K ﹤0.01%
43
MRNA icon
675
Moderna
MRNA
$21.5B
$5.95K ﹤0.01%
85

Similar funds

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.